knowledge -WSS

knowledge

author：Wikipedia 2025-08-12 09:10:13 - browse：88

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： The strange history of BMI, the body mass index

WSS

Here's how to stay safe from wildfire smoke amid reduced air quality

Biotech lab space demand falls sharply

STAT Virtual Event: Putting AI to the Test

FDA panel to weigh approval of NurOwn, controversial ALS drug

Thermo Fisher plant for manufacturing gene therapies to expand

Senators: Long

focus

knowledge

focus

Psychedelics group wrestles with new pharma identity

How AI helped researchers track recovery from depression

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biotech lab space demand falls sharply

Apple is now the first public company to be valued at $3 trillion

Here's how to stay safe from wildfire smoke amid reduced air quality

How one medical school became remarkably diverse

Senators: Long

Duchenne breakthrough therapy leaves behind pioneering families

What Congress can do to address the rural doctor shortage

focus

Why do we get seasonal allergies?

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Supreme Court rules employers must be more accommodating of religious observance

Drug for rare kidney disease narrowly misses mark in clinical trial

Ukrainian soldiers say they owe lives to US

focus

explore

hotspot

Wikipedia